Glycosciences.DB structure entry #766:
b-D-Galp-(1-3)-b-D-GalpNAc-(1-4)+
|
b-D-Galp-(1-4)-b-D-Glcp-(1-1)-sphingosine-(2-1)-<2-chloroacetate>
|
a-D-Neup5Ac-(2-3)+
Corresponding entries: 22
: 1 
: 643 
Literature references: 51 - 5 of 5 literature references
Reference #12644
Schneider JS; Distefano L
Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: Effects of dose and extent of lesion
Published 1995 in Neuropharmacology, 34: 489-493
Reference contains 2 structures
Reference #12434
Polo A; Kirschner G; Guidotti A; Costa E
Brain content of glycosphingolipids after oral administration of monosialogangliosides GM1 and LIGA20 to rats
Published 1994 in Mol Chem Neuropathol, 21: 41-53
Reference contains 2 structures
Reference #12634
Schneider JS; DiStefano L
Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism
Published 1994 in Neurology, 44: 748-750
Reference contains 3 structures
Reference #127
Manev H; Guidotti A; Costa E
Protection by gangliosides against excitotoxicity
Published 1993 in Adv Lipid Res, 25: 269-288
Reference contains 5 structures
Reference #12648
Schneider JS; DiStefano L
LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment
Published 1993 in Neuroreport, 5: 103-104
Reference contains 2 structures